-
ORPHY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
Orphazyme A/S (ORPHY)
Company Profile
Quarter (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 26 |
Opened positions | 4 |
Closed positions | 4 |
Increased positions | 7 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 47.64 mm |
Total shares | 7.47 mm |
Total puts | 144.40 k |
Total calls | 325.20 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
LSP V Cooperatieve U.A. | 2.60 mm | $6.26 mm |
Sunstone Life Science Ventures Fund Ii K/S | 1.79 mm | $19.20 mm |
Cooperatieve AESCAP Venture I U.A. | 1.76 mm | $18.86 mm |
Renaissance Technologies | 271.99 k | $656.00 k |
Geode Capital Management | 177.07 k | $426.00 k |
Two Sigma Investments | 141.12 k | $340.00 k |
Profund Advisors | 127.52 k | $307.00 k |
Susquehanna International | 114.37 k | $276.00 k |
Optiver Holding B.V. | 106.84 k | $358.00 k |
Citadel Advisors | 95.01 k | $229.00 k |